SIRT1 and AROS suppress doxorubicin-induced apoptosis via inhibition of GSK3β activity in neuroblastoma cells.

Animal Cells and Systems
Jeong Woo KimEun-Joo Kim

Abstract

SIRT1, the best-characterized member of the sirtuin family of deacetylases, is involved in cancer, apoptosis, inflammation, and metabolism. Active regulator of SIRT1 (AROS) was the first identified direct regulator of SIRT1. An increasing number of reports have indicated that SIRT1 plays an important role in controlling brain tumors. Here, we demonstrated that depletion of SIRT1 and AROS increases doxorubicin-mediated apoptosis in human neuroblastoma SH-SY5Y cells. Glycogen synthase kinase 3β (GSK3β) promoted doxorubicin-mediated apoptosis, but this effect was abolished by overexpression of SIRT1 and AROS. Interestingly, SIRT1 and AROS interacted with GSK3β and increased inhibitory phosphorylation of GSK3β on Ser9. Finally, we determined that AROS cooperates with SIRT1 to suppress GSK3β acetylation. Taken together, our results suggest that SIRT1 and AROS inhibit GSK3β activity and provide additional insight into drug resistance in the treatment of neuroblastoma.

References

Dec 26, 2001·Chemical Reviews·A AliJ R Woodgett
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Piyajit WatcharasitRichard S Jope
Sep 14, 2002·The Journal of Biological Chemistry·Ling SongRichard S Jope
Dec 10, 2003·Neuroreport·Gautam N Bijur, Richard S Jope
Sep 21, 2004·Nature Reviews. Neuroscience·Paul S MischelStanley F Nelson
Jul 19, 2005·Nature Reviews. Neuroscience·Wolfgang Löscher, Heidrun Potschka
Feb 9, 2008·Neurotoxicology·Miguel Angelo LopesMaria de Lourdes Bastos
Jun 19, 2010·The New England Journal of Medicine·John M Maris
Nov 24, 2011·Frontiers in Molecular Neuroscience·Oksana Kaidanovich-Beilin, James Robert Woodgett
Apr 28, 2012·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Jing-Xin MaJia Liu
Mar 12, 2013·Molecular Neurobiology·Xiao-Hong LiSai Zhang
Jun 4, 2013·European Journal of Pharmacology·Yedong ChengYang Yang
Feb 11, 2014·Neuron·A Zara Herskovits, Leonard Guarente
Oct 29, 2014·International Journal of Cancer. Journal International Du Cancer·Theresa ThorJohannes H Schulte
Mar 10, 2015·Critical Reviews in Oncogenesis·Hui YangGuangwei Liu
Nov 26, 2015·IUBMB Life·Nydia Tejeda-Muñoz, Martha Robles-Flores
Feb 2, 2017·Expert Review of Anticancer Therapy·Sarah B WhittlePeter E Zage
Jul 18, 2017·Advances in Biological Regulation·Miguel A HermidaNick R Leslie
Mar 13, 2018·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Caroline C SwiftAdina L Alazraki
Aug 1, 2018·The Journal of Biological Chemistry·Stephen J BautistaCostin N Antonescu
Oct 24, 2018·Molecular and Cellular Biochemistry·Jingxuan FuTao Zhang
Nov 6, 2018·Blood Advances·James J Ignatz-HooverDavid N Wald
Apr 28, 2019·The Journal of Biological Chemistry·Falguni DasGoutam Ghosh Choudhury

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Immunoprecipitation
electrophoresis
transfection
flow cytometry
confocal microscopy
acetylation

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.